Skip to main content

Table 2 Year-specific opioid filling volumes and rates across the entire study cohort in oxycodone 5-mg equivalents. Mean (standard deviation) or sample size and percentage displayed

From: Opioid legislation and narcotic filling in total hip arthroplasty: descriptive study of time and state-level trends in the United States

Timeframe Oxycodone 5-mg equivalents (first prescription) Oxycodone 5-mg equivalents (cumulative) 1 or more opioid prescriptions 2 or more opioid prescriptions Initial volume > 90 oxycodone 5-mg equivalents
2010 56.2 (38.9) 151.9 (105.3) 12,917 (59.5%) 8171 (37.6%) 1387 (6.4%)
2011 55.8 (38.7) 141.8 (105.7) 39,590 (64%) 26,208 (42.4%) 4319 (7%)
2012 56.8 (38.6) 140.8 (104.9) 42,277 (64%) 27,684 (41.9%) 4901 (7.4%)
2013 57.5 (38.3) 140.2 (104.5) 46,734 (66.2%) 30,102 (42.6%) 5666 (8%)
2014 58.7 (38.8) 139.8 (102.4) 50,784 (67.6%) 32,575 (43.4%) 6508 (8.7%)
2015 62.2 (39.9) 140.4 (101) 50,271 (67.8%) 31,286 (42.2%) 7622 (10.3%)
2016 61.5 (39.6) 136.8 (99.7) 51,373 (69.8%) 31,429 (42.7%) 7311 (9.9%)
2017 57.7 (37.3) 126.5 (96.1) 49,009 (70.2%) 29,448 (42.2%) 5619 (8.1%)
2018 51.7 (33.9) 111.7 (91.3) 19,943 (69.9%) 11,484 (40.3%) 1590 (5.6%)